Lv0
0 积分 2022-12-30 加入
Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial
16小时前
待确认
Teprotumumab vs Intravenous Methylprednisolone for Thyroid Eye Disease
1个月前
已完结
Retracted: Efficacy and safety of mycophenolate mofetil in patients with active moderate‐to‐severe Graves’ orbitopathy
1个月前
已完结
Efficacy of Tocilizumab in Patients With Moderate-to-Severe Corticosteroid-Resistant Graves Orbitopathy: A Randomized Clinical Trial
1个月前
已完结
Randomized Controlled Trial of Rituximab in Patients With Graves' Orbitopathy
1个月前
已完结
Graves disease: latest understanding of pathogenesis and treatment options
1个月前
已完结
First-line ceritinib versus platinum-based chemotherapy in advanced ALK -rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
2个月前
已完结
Chemotherapy-free neoadjuvant pembrolizumab combined with trastuzumab and pertuzumab in HER2-enriched early breast cancer (WSG-KEYRICHED-1): a single-arm, phase 2 trial
2个月前
已完结
Understanding weight regain after a nutritional weight loss intervention: Systematic review and meta-analysis
2个月前
已完结
Combination of TAS-102 and bevacizumab as third-line treatment for metastatic colorectal cancer: TAS-CC3 study
4个月前
已完结
皖公网安备34019202002308
